AI in Medical Writing Market Size Worth $2,072.30 Million by 2032 | CAGR: 12.1%

AI in Medical Writing Market Size Worth $2,072.30 Million by 2032 | CAGR: 12.1%

The global AI in medical writing market size is expected to reach USD 2,072.30 million by 2032, according to a new study by Polaris Market Research. The report “AI in Medical Writing Market Share, Size, Trends, Industry Analysis Report, By Type (Scientific Writing, Clinical Writing, Type Writing), By End-use (Medical Devices, Pharmaceutical, Biotechnology), By Region, And Segment Forecasts, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing acceptance of machine learning, particularly Artificial Intelligence (AI), in the healthcare industry is a key driver of market expansion. AI-powered solutions have shown significant potential in improving patient care, diagnostic accuracy, drug discovery, and treatment outcomes, leading to increased adoption by healthcare providers and pharmaceutical companies.

Additionally, the rising demand to reduce healthcare expenditures and the increasing R&D investments by pharmaceutical companies to optimize their processes and reduce costs are driving the market growth. AI-powered medical writing tools and solutions offer the potential to streamline various tasks, increase efficiency, and minimize manual efforts, ultimately leading to cost savings for healthcare organizations and pharmaceutical firms.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:

During the COVID-19 pandemic, many pharmaceutical companies faced budgetary limitations due to economic uncertainties and healthcare system strain. As a result, they had to reevaluate their spending, including investments in research and development. This led to a reduction in R&D budgets and potentially affected their investment in traditional medical writing resources.

In response to the pandemic's challenges and the growing demand for innovative therapies, medical device, biotechnology, and life science companies recognized the need to invest in medical writers. They saw the potential of AI-powered medical writing tools to streamline and enhance the efficiency of the medical writing process. AI-driven solutions could help medical writers generate accurate and reliable reports, conduct literature reviews faster, and facilitate data extraction and summarization, all of which were essential during the pandemic.

As a result, there was an increasing intention among healthcare companies to boost their investment in AI-powered medical writing solutions to address the evolving demands of the healthcare industry during the COVID-19 pandemic and beyond. This increasing demand for AI in the healthcare industry was driven by the need for innovative and efficient solutions to cope with the challenges posed by the pandemic and to accelerate the development and dissemination of critical medical information.

AI in Medical Writing Market Report Highlights

  • Typewriting segment held the largest share, as it is compulsory to submit all regulatory document requirements to the agencies, and maintenance of electronic health records
  • Pharmaceutical segment holds the largest share, as drug approval process requires several regulatory filings, documentation, and electronic records of clinical trials
  • North holds the largest share, owing to presence of companies engaged in regulatory films with innovative services, and increasing investments on drug trials
  • The global key market players include Parexel International, Trilogy Writing & Consulting, Freyr, Cactus Communications, and GENINVO.

Polaris Market Research has segmented the AI in medical writing market report based on type, end use, and region:

AI in Medical Writing, Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Clinical Writing
  • Type Writing
  • Scientific Writing
  • Others

AI in Medical Writing, End Use Outlook (Revenue - USD Million, 2023 - 2032)

  • Medical Devices
  • Pharmaceutical
  • Biotechnology
  • Others

AI in Medical Writing, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

AI in Medical Writing Market Report Scope

Report Attributes


Market size value in 2023

USD 722.75 million

Revenue forecast in 2032

USD 2,072.30 million


12.4% from 2023 – 2032

Base year


Historical data

2019 – 2021

Forecast period

2023 – 2032

Quantitative units

Revenue in USD million and CAGR from 2023 to 2032

Segments covered

By Type, End Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key companies

Parexel International, Trilogy Writing & Consulting, Freyr, Cactus Communications, and GENINVO

For Specific Research Requirements

Request for Customized Report